Related Experiment Video

Updated: Jan 25, 2026

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
09:16

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

8.1K

Molecular mechanisms of arrhythmogenic cardiomyopathy

Karyn M Austin1, Michael A Trembley1, Stephanie F Chandler1

  • 1Basic and Translational Cardiovascular Research and Inherited Arrhythmias Programs, Department of Cardiology, Boston Children's Hospital, Boston, MA, USA.

Nature Reviews. Cardiology
|April 28, 2019
PubMed

Insights

Arrhythmogenic cardiomyopathy stems from desmosome gene mutations, leading to heart dysfunction. Research highlights WNT, Hippo-YAP, and TGF-β pathways in its pathogenesis, offering potential therapeutic targets.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Genetic Medicine

Background:

  • Arrhythmogenic cardiomyopathy (ACM) is a genetic heart disorder causing arrhythmias and fibrofatty tissue replacement.
  • Desmosome gene mutations are primary drivers, found in ~50% of ACM patients.
  • Underlying mechanisms of myocardial damage and arrhythmia risk are not fully understood.

Purpose of the Study:

  • To review and discuss molecular mechanisms in arrhythmogenic cardiomyopathy pathogenesis.
  • To highlight key signaling pathways implicated in ACM development.
  • To identify potential therapeutic targets for ACM.

Main Methods:

  • Review of recent scientific literature on arrhythmogenic cardiomyopathy.
  • Analysis of data from animal models, induced pluripotent stem cells, and other disease models.
  • Focus on signaling pathways including WNT, Hippo-YAP, and TGF-β.

Main Results:

  • Advances in disease models have illuminated pathogenic mechanisms.
  • Several key signaling pathways (WNT, Hippo-YAP, TGF-β) are central to ACM.
  • Preclinical studies show promise for modulating these pathways therapeutically.

Conclusions:

  • Understanding ACM pathogenesis involves key signaling pathways.
  • Targeting WNT, Hippo-YAP, and TGF-β pathways offers therapeutic potential.
  • Further research is crucial for developing effective ACM treatments.

More Related Videos

Use of the TetON System to Study Molecular Mechanisms of Zebrafish Regeneration10:22

Use of the TetON System to Study Molecular Mechanisms of Zebrafish Regeneration

Published on: June 25, 2015

11.1K
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.4K

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
519
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
454
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
498
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
374
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
552
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
333